Residual cardiovascular risk among people with diabetes

Type 2 diabetes (T2D) is a growing health concern across both developed and developing countries. Cardiovascular disease (CVD) remains the major cause of increased mortality in this patient population. In recent years, effective low density lipoprotein lowering treatments and other risk reduction st...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes, obesity & metabolism obesity & metabolism, 2019-04, Vol.21 (S1), p.28-38
Hauptverfasser:	Dash, Satya, Leiter, Lawrence A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Arteriosclerosis cardiovascular disease Cardiovascular diseases clinical trial Developing countries Diabetes Diabetes mellitus Diabetes mellitus (non-insulin dependent) dyslipidaemia LDCs lipid‐lowering therapy Lipoproteins Low density lipoprotein Metabolic disorders
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!